Cargando…

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

Adult-onset Still’s disease (AOSD) is a rare inflammatory disease of unknown etiology typically characterized by episodes of spiking fever, evanescent rash, arthralgia, leukocytosis, and hyperferritinemia. The pivotal role of interleukin (IL)-1 and other pro-inflammatory cytokines gives rise to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galozzi, Paola, Baggio, Chiara, Bindoli, Sara, Oliviero, Francesca, Sfriso, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160871/ https://www.ncbi.nlm.nih.gov/pubmed/30298010 http://dx.doi.org/10.3389/fphar.2018.01074

Ejemplares similares

Progress in Biological Therapies for Adult-Onset Still’s Disease
por: Galozzi, Paola, et al.
Publicado: (2022)

IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
por: Baggio, Chiara, et al.
Publicado: (2023)

(18)F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease
por: Bindoli, Sara, et al.
Publicado: (2020)

Autoinflammatory Features in Gouty Arthritis
por: Galozzi, Paola, et al.
Publicado: (2021)

Autoinflammatory Mechanisms in Crystal-Induced Arthritis
por: Oliviero, Francesca, et al.
Publicado: (2020)

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors
por: Bindoli, Sara, et al.
Publicado: (2023)

Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease
por: Vitale, Antonio, et al.
Publicado: (2020)

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
por: Colafrancesco, Serena, et al.
Publicado: (2017)

Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study
por: Bindoli, Sara, et al.
Publicado: (2019)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease
por: Brachat, A, et al.
Publicado: (2015)

Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
por: Vitale, Antonio, et al.
Publicado: (2019)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease
por: Feng, Jin, et al.
Publicado: (2023)

Clinical Overlapping in Autoinflammatory Diseases: The Role of Gene Duplication
por: Galozzi, Paola, et al.
Publicado: (2017)

Editorial: IL-1 Inhibition
por: Oliviero, Francesca, et al.
Publicado: (2019)

Anti-Inflammatory and Hypouricemic Effect of Bioactive Compounds: Molecular Evidence and Potential Application in the Management of Gout
por: Scanu, Anna, et al.
Publicado: (2022)

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro
por: Oliviero, Francesca, et al.
Publicado: (2013)

Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease
por: Caso, Francesco, et al.
Publicado: (2015)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings
por: Hur, Peter, et al.
Publicado: (2021)

Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz, Joachim, et al.
Publicado: (2015)

Leucocyte Abnormalities in Synovial Fluid of Degenerative and Inflammatory Arthropathies
por: Baggio, Chiara, et al.
Publicado: (2023)

Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab
por: Ghannam, Khetam, et al.
Publicado: (2021)

Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses
por: Dunger-Baldauf, Cornelia, et al.
Publicado: (2022)

Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice
por: Oliviero, Francesca, et al.
Publicado: (2021)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease
por: Shaul, Eliana, et al.
Publicado: (2022)

Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
por: Kedor, Claudia, et al.
Publicado: (2020)

Adult onset Still's disease: Role of scintigraphy
por: Nilegaonkar, Sujit, et al.
Publicado: (2012)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

Post-traumatic arthritis: overview on pathogenic mechanisms and role of inflammation
por: Punzi, Leonardo, et al.
Publicado: (2016)

The still mysterious roles of cysteine-containing glutathione transferases in plants
por: Lallement, Pierre-Alexandre, et al.
Publicado: (2014)

Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes
por: Vitale, Antonio, et al.
Publicado: (2020)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Adult-Onset Still’s Disease
por: Mitrovic, Stéphane, et al.
Publicado: (2019)

Adult-Onset Still’s Disease
por: Efthimiou, Petros, et al.
Publicado: (2018)

Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics
por: Giuliani, Anna Lisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uskmn8rp8fuo4o8f1atunhckik